Evidence map›Paper›PMID 40546389›Full record

ArticleFood and waterborne parasitology2025

Design and immunological evaluation of a multi-epitope vaccine candidate against

Zahra Hosseininejad, Ahmad Daryani, Mahdi Fasihi-Ramandi, Hossein Asgarian-Omran, Tooran Nayeri, Samira Dodangeh, Afsaneh Amouei, Javad Javidnia, Sabah Mayahi, Shahabeddin Sarvi and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Food and waterborne parasitology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. HarnessingAnnals of medicine · 2026
    Review
  2. Article
  3. Advances and Translational Challenges inVeterinary sciences · 2026
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zahra HosseininejadDepartment of Laboratory Sciences, Estahban Faculty of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Ahmad DaryaniToxoplasmosis Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Mahdi Fasihi-RamandiMolecular Biology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Hossein Asgarian-OmranImmunology Department, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Tooran NayeriInfectious and Tropical Diseases Research Center, Dezful University of Medical Sciences, Dezful, Iran.
Samira DodangehClinical Research Development Unit of Advanced Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
Afsaneh AmoueiToxoplasmosis Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Javad JavidniaInvasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Sabah MayahiInvasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Shahabeddin SarviToxoplasmosis Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Sargis A AghayanLaboratory of Molecular Parasitology, Scientific Center of Zoology and Hydroecology, Yerevan, Armenia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Toxoplasmosis, caused by the apicomplexan parasite

Indexed as

GRA1MIC13Multi-epitopeSAG1Toxoplasma gondiiVaccine

Identifiers

PMID40546389
PMCPMC12177152

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.